Active-ingredient Dossier
Fenofibrate
Active-ingredient Dossier for Fenofibrate (fibric acid derivative). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: FENOFIBRATE
- Brand: LIPIDIL
- Brand: APO-FENOFIBRATE
- Brand: ARX-FENOFIBRATE
- Brand: FENOCOL
- Brand: FENOFIBRATE
- Therapeutic area: Cardiology
- Therapeutic area: Endocrinology
What is
Fenofibrate Fenofibrate is a fibric acid derivative.
Australian brands containing
Fenofibrate — FENOFIBRATE — LIPIDIL — APO-FENOFIBRATE — ARX-FENOFIBRATE — FENOCOL — FENOFIBRATE-WGR — FENOCOL — FENOCOL — FENOCOL — FENOCOL
Therapeutic areas
Fenofibrate is registered in cardiology, with 16 brands containing the ingredient on the ARTG.
Sponsor landscape
Fenofibrate is marketed by ten sponsors: Lupin, Viatris, Southern Cross Pharma, Cipla, Arrotex Pharmaceuticals, and Accelagen.
PBS and regulatory activity
One brand containing fenofibrate has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest AusPAR on record dates to 8 October 2013, and one brand has an AusPAR on file.